Patents by Inventor William Mounts
William Mounts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8916029Abstract: A contaminated solvent recycling system is disclosed and claimed. The system comprises a distillation vessel having an upper distillation zone and a separate, lower, waste collection zone. A heater heats contaminated solvent feed within the distillation zone to distill off the solvent. By separating the distillation zone from the waste collection zone, the distillation zone can process consecutive batches of contaminated solvent feed. The waste collection zone can accommodate waste accumulating from the distillation process for extended periods of time between waste removal operations.Type: GrantFiled: December 3, 2003Date of Patent: December 23, 2014Assignee: ChemChamp, LLCInventors: Charles Harland, Dennis William Mount, Mathieu Fredette
-
Publication number: 20110010183Abstract: Provided is a method for conducting a market survey, including identifying a survey topic and administrating the survey to a survey participant. The survey includes requesting the participant to enter text expressing an emotion regarding a topic of the survey. The survey also requests the participant enter a metric indicating the level of emotional intensity in relation to the text expressing an emotion. The survey administrator correlates an emotionally based theme to the emotion expressing text, and assigns a second emotion measuring metric to the emotionally based theme. The administrator may additionally present a set of images to the survey participant and request the participant to select an image to associate with the text expressing an emotion.Type: ApplicationFiled: May 19, 2010Publication date: January 13, 2011Applicant: Drumcircle LLCInventors: Anne Manning, William Mount
-
Publication number: 20090114521Abstract: A contaminated solvent recycling system comprises a distillation vessel having a distillation zone and a separate waste collection zone and heating means for heating contaminated solvent feed within the distillation zone vessel to distill off the solvent. By separating the distillation zone from the waste collection zone, the distillation zone can be made small enough to process small consecutive batches of contaminated solvent feed whilst the waste collection zone can be made large enough to accommodate waste accumulating from the distillation process for extended periods of time between waste removal operations.Type: ApplicationFiled: December 3, 2003Publication date: May 7, 2009Inventors: Charles Harland, Dennis William Mount, Mathieu Fredette
-
Patent number: 7368038Abstract: An anti-pressure system for a vessel which is subject to internal pressure created by heating or boiling of its contents, the system including first and second spaced-apart outlets for vapor to exit the vessel, each outlet having a first side communicating with the vessel interior and a second side communicating with the vessel exterior. The invention provides a reliable method of protecting a normally un-pressurized vessel, such as an autoclave, distillation vessel, boiler or the like, from dangerous pressure build-up, resulting from its vapor outlet being blocked, regardless of what other pressure release devices, if any, may be present on the vessel.Type: GrantFiled: August 23, 2001Date of Patent: May 6, 2008Assignee: Chem-Champ (Barbados) Inc.Inventor: Dennis William Mount
-
Publication number: 20080070797Abstract: The present invention provides nucleic acid arrays and methods of using the same for expression profiling of human protease and/or osteoarthritis genes. The nucleic acid arrays of the present invention include one or more substrate supports. A substantial portion of all polynucleotide probes that are stably attached to the substrate support(s) can hybridize under stringent or nucleic acid array hybridization conditions to human protease or osteoarthritis genes. In one embodiment, the nucleic acid arrays of the present invention include a plurality of probe sets, each of which can hybridize under stringent or nucleic acid array hybridization conditions to a different respective tiling sequence selected from Attachment C, or the complement thereof.Type: ApplicationFiled: August 8, 2007Publication date: March 20, 2008Applicant: WyethInventor: William Mounts
-
Publication number: 20080009008Abstract: The present invention provides novel isolated BFLP1698 polynucleotides and polypeptides encoded by the BFLP1698 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP1698 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP1698 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP1698 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.Type: ApplicationFiled: April 17, 2007Publication date: January 10, 2008Applicant: WyethInventors: Margot O'Toole, William Mounts, Negin Shojaee
-
Publication number: 20070031850Abstract: Nucleic acid arrays and methods of using the same for concurrent or discriminable detection of different strains of a non-viral species. In many embodiments, the nucleic acid arrays of the present invention include probes that are specific to different respective strains of a non-viral species. In many other embodiments, the nucleic acid arrays of the present invention include probes that are common to two or more different strains of the non-viral species. In one embodiment, the non-viral species is Staphylococcus aureus, and the different Staphylococcus aureus strains include COL, N315, Mu50, EMRSA-16, MSSA-476, and 8325 strains. In another embodiment, a nucleic acid array of the present invention includes polynucleotide probes capable of hybridizing under stringent or nucleic acid array hybridization conditions to respective sequences selected from SEQ ID NOs: 1 to 7,852, or the complements thereof.Type: ApplicationFiled: June 3, 2004Publication date: February 8, 2007Inventors: William Mounts, Maryann Whitley, Ellen Murphy
-
Publication number: 20070009899Abstract: The present invention provides nucleic acid arrays and methods of using the same for detecting gene expression in animal models of osteoarthritis or other inflammatory diseases. The nucleic acid arrays of the present invention comprise polynucleotide probes for genes that are differentially expressed in osteoarthritis-affected cartilage tissues as compared to non-osteoarthritic cartilage tissues. In one embodiment, a nucleic acid array of the present invention comprises a plurality of polynucleotide probe sets, each of which is capable of hybridizing under stringent or nucleic acid array hybridization conditions to a different respective tiling sequence selected from Table C, or the complement thereof.Type: ApplicationFiled: October 4, 2004Publication date: January 11, 2007Inventor: William Mounts
-
Publication number: 20060228356Abstract: The present invention provides novel isolated BFLP0169 polynucleotides and polypeptides encoded by the BFLP0169 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP0169 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP0169 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP0169 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.Type: ApplicationFiled: February 15, 2006Publication date: October 12, 2006Applicant: WyethInventors: Margot O'Toole, William Mounts, Negin Shojaee
-
Publication number: 20060160121Abstract: The present invention provides probe arrays and methods of using the same for concurrent and discriminable detection of multiple strains of different species. In one aspect, the probe arrays of the present invention are nucleic acid arrays comprising (1) a first group of probes, each of which is specific to a different respective strain of a first species; and (2) a second group of probes, each of which is specific to a different respective strain of a second species. In many embodiments, the nucleic acid arrays of the present invention further include a third group of probes, each of which is specific to a different strain of a third species. In one example, a nucleic acid array of the present invention includes probes for sequences selected from SEQ ID NOs: 1 to 18,598, and can discriminably detect different strains of Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus epidermidis.Type: ApplicationFiled: February 7, 2006Publication date: July 20, 2006Applicant: WyethInventors: William Mounts, Ellen Murphy, Stephen Olmsted
-
Publication number: 20060073496Abstract: The present invention generally relates to a method for an improved treatment for Alzheimer's disease (AD) using immunotherapy, e.g., immunotherapy targeting ? amyloid (A?), e.g., immunotherapy based on AN1792. In one embodiment, the method allows for predicting an adverse clinical response, and therefore allows for an improved safety profile of AN1792. In another embodiment, the method allows for predicting a favorable clinical response, and therefore allows for an improved efficacy profile of AN1792. The methods of the present invention may be combined to predict a favorable clinical response and the lack of an adverse clinical response.Type: ApplicationFiled: July 20, 2005Publication date: April 6, 2006Inventors: Margot O'Toole, Andrew Dorner, Derek Janszen, Donna Slonim, William Mounts, Padmalatha Reddy, Andrew Hill
-
Publication number: 20060010513Abstract: The present invention provides an oligonucleotide array capable of identifying genes and related pathways involved with the induction of a particular phenotype by a cell line, e.g., the genes and related pathways involved with the induction of transgene expression by the cell line. The invention is particularly useful when there is little or no information about the genome of the cell line being studied, because it provides methods for identifying consensus sequences for known and previously undiscovered genes, and for designing oligonucleotide probes to the identified consensus sequences. Additionally, when the array is to be used to determine optimal conditions for expression of a transgene by the cell line, the invention teaches methods of including oligonucleotide probes to transgene sequences in the array. The invention also provides methods of using the array to identify genes and related pathways involved with the induction of a particular cell line phenotype.Type: ApplicationFiled: May 11, 2005Publication date: January 12, 2006Inventors: Mark Melville, Timothy Charlebois, William Mounts, Louane Hann, Martin Sinacore, Mark Leonard, Eugene Brown, Christopher Miller, Gene Lee
-
Publication number: 20060003958Abstract: The present invention provides an oligonucleotide array capable of identifying genes and related pathways involved with the induction of a particular phenotype by a cell line, e.g., the genes and related pathways involved with the induction of transgene expression by the cell line. The invention is particularly useful when there is little or no information about the genome of the cell line being studied, because it provides methods for identifying consensus sequences for known and previously undiscovered genes, and for designing oligonucleotide probes to the identified consensus sequences. Additionally, when the array is to be used to determine optimal conditions for expression of a transgene by the cell line, the invention teaches methods of including oligonucleotide probes to transgene sequences in the array. The invention also provides methods of using the array to identify genes and related pathways involved with the induction of a particular cell line phenotype.Type: ApplicationFiled: May 11, 2005Publication date: January 5, 2006Inventors: Mark Melville, Timothy Charlebois, William Mounts, Louane Hann, Martin Sinacore, Mark Leonard, Eugene Brown, Christopher Miller, Gene Lee
-
Publication number: 20050287570Abstract: The present invention provides probe arrays for expression profiling of rat genes. Each probe array comprises a plurality of probes, each of which is directed to a rat gene that encodes a sequence selected from SEQ ID NOs: 1-8,192. Suitable probes for the present invention include polynucleotides that can hybridize under stringent or nucleic acid array hybridization conditions to the RNA transcripts, or the complements thereof, of the corresponding rat genes. Suitable probes also include antibodies or other protein-binding molecules that can bind to the protein products of the corresponding rat genes. In one embodiment, a probe array of the present invention includes one or more probes, each of which is directed to a rat gene that encodes a sequence selected from SEQ ID NOs: 7622 and 8084-8124.Type: ApplicationFiled: May 25, 2005Publication date: December 29, 2005Applicant: WyethInventor: William Mounts
-
Publication number: 20050221354Abstract: The present invention provides nucleic acid arrays and methods of using the same for detecting or monitoring expression profiles of drug target genes. Non-limiting examples of drug target genes include kinase genes, phosphatase genes, protease genes, G-protein coupled receptor genes, nuclear hormone receptor genes, and ion channel genes. The present invention also provides methods of using nucleic acid arrays for the identification or validation of drugs or drug targets. In one embodiment, a nucleic acid array of the present invention is concentrated with probes for drug target genes. These probes constitute a substantial portion of all of the polynucleotide probes that are stably attached to the nucleic acid array, and can hybridize under stringent or nucleic acid array hybridization conditions to the tiling sequences selected from Attachment C, or the complements thereof.Type: ApplicationFiled: February 18, 2005Publication date: October 6, 2005Applicant: WyethInventor: William Mounts
-
Publication number: 20050119208Abstract: The present invention provides novel isolated BFLP1698 polynucleotides and polypeptides encoded by the BFLP1698 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP1698 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP1698 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP1698 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.Type: ApplicationFiled: November 21, 2003Publication date: June 2, 2005Inventors: Margot O'Toole, William Mounts, Negin Shojaee
-
Publication number: 20050118625Abstract: The present invention provides nucleic acid arrays and methods of using the same for expression profiling of human protease and/or osteoarthritis genes. The nucleic acid arrays of the present invention include one or more substrate supports. A substantial portion of all polynucleotide probes that are stably attached to the substrate support(s) can hybridize under stringent or nucleic acid array hybridization conditions to human protease or osteoarthritis genes. In one embodiment, the nucleic acid arrays of the present invention include a plurality of probe sets, each of which can hybridize under stringent or nucleic acid array hybridization conditions to a different respective tiling sequence selected from Attachment C, or the complement thereof.Type: ApplicationFiled: October 4, 2004Publication date: June 2, 2005Inventor: William Mounts
-
Patent number: D455813Type: GrantFiled: June 11, 2001Date of Patent: April 16, 2002Inventor: Dennis William Mount
-
Patent number: D525003Type: GrantFiled: February 23, 2004Date of Patent: July 11, 2006Assignee: ChemChamp (Barbados) Inc.Inventors: Dennis William Mount, Charles Harland, Mathieu Fredette
-
Patent number: D572869Type: GrantFiled: June 17, 2005Date of Patent: July 8, 2008Assignee: ChemChamp (Barbados) Inc.Inventors: Dennis William Mount, Mathieu Fredette